GNUBIO

gnubio-logo

GnuBIO is a developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which provides a scalable desktop sequencing system that allows interrogation of single genes, gene panels, and whole genomes. Using a proprietary DNA sequencing system, the GnuBIOโ€™s platform encompasses all the steps required for DNA sequencing into a single platform including target selection and enrichment, DNA amplification, DNA sequencing and analysis. GnuBIOโ€™s cutting-edge platform provides a single user interface, and a single step process, which rapidly produces results to hours versus days.

#SimilarOrganizations #People #Website #More

GNUBIO

Industry:
Biotechnology Genetics Health Care Medical Device

Founded:
2009-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.gnubio.com

Total Employee:
11+

Status:
Active

Contact:
617 446 6744

Email Addresses:
[email protected]

Total Funding:
22.5 M USD

Technology used in webpage:
SSL By Default WordPress IPv6 Google Maps Contact Form 7 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL


Similar Organizations

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Current Employees Featured

not_available_image

Tal Raz
Tal Raz VP, Molecular Biology @ GnuBIO
VP, Molecular Biology
2010-12-01

Founder


john-boyce_image

John Boyce

Official Site Inspections

http://www.gnubio.com

  • Host name: 172.67.195.121
  • IP address: 172.67.195.121
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "GnuBIO"

GnuBIO - Crunchbase Company Profile & Funding

GnuBIO is a developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which โ€ฆSee details»

GnuBIO | About GnuBIO

Sepehr leads the engineering efforts at GnuBIO, Inc and is responsible for overall product development and commercialization strategy. Prior to joining GnuBIO, Sepehr was Director of โ€ฆSee details»

Cutting-Edge DNA Sequencing with GnuBIO's โ€ฆ

GnuBIO provides the only fully-integrated DNA sequencing platform designed to meet the workflows of both research and clinical laboratories. Utilizing emulsion microfluidics, GnuBIO has been able to create a scalable DNA sequencing โ€ฆSee details»

GnuBIO, Inc - LinkedIn

GnuBIO, Inc | 2,354 followers on LinkedIn. GnuBIO Inc is a genomics company based in Cambridge, MA. We are pioneers in the field of DNA sequencing technology for the diagnostic โ€ฆSee details»

GnuBIO Company Profile 2024: Valuation, Investors, Acquisition

GnuBIO General Information Description. Manufacturer of DNA sequencing technology designed to meet the workflows of both research and clinical laboratories. The company utilizes โ€ฆSee details»

GnuBIO - VentureRadar

GnuBIO (www.gnubio.com) is a privately-held company developing next-generation desktop DNA sequencing technology that will compartmentalize the entire DNA sequencing process, โ€ฆSee details»

GnuBIO - Tech Stack, Apps, Patents & Trademarks - Crunchbase

GnuBIO is a developer of scalable DNA sequencing technology for the diagnostic and applied markets.See details»

GnuBIO Inc. Company Profile | Hercules, CA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for GnuBIO Inc. of Hercules, CA. Get the latest business insights from Dun & Bradstreet.See details»

Bio-Rad Acquires GnuBIO and DNA Sequencing Technology

Hercules, CA April 10, 2014 Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global manufacturer and distributor of life science research and clinical diagnostic products, today โ€ฆSee details»

GnuBIO - Crunchbase

GnuBIO is a developer of scalable DNA sequencing technology for the diagnostic and applied markets.See details»

Bio-Rad Buys GnuBio; Will Focus on NGS-based Dx for

Apr 15, 2014 GnuBio CEO and Co-founder John Boyce will head up the Cambridge location of Bio-Rad's Digital Biology Center. While the GnuBio technology will continue to be developed โ€ฆSee details»

GnuBIO | Bio-Rad Acquires GnuBIO, Developer of Droplet-Based โ€ฆ

GnuBIO, has developed a DNA sequencing solution that integrates the entire sample preparation workflow on a chip, from sample capture, PCR, and sequencing, to informatics. This capability โ€ฆSee details»

Bio-Rad Shutters Former GnuBio Facility as Part of Digital

Sep 21, 2017 GnuBio had been developing a droplet-based platform for targeted next-generation sequencing, which used a pico-injector technology developed by co-founder David โ€ฆSee details»

Bio-Rad Acquires Sequencing Technology Company GnuBIO

Apr 11, 2014 GnuBIO is a privately-held life sciences company that has developed a droplet-based DNA sequencing technology.See details»

GnuBIO - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โ€ฆSee details»

GnuBIO Makes First Sequencing Data Available to Thought โ€ฆ

Apr 6, 2011 GnuBIO, Inc is a private company,www.gnubio.com, and a pioneer in the field of scalable DNA sequencing technology for the Diagnostic and Applied Markets.Utilizing its โ€ฆSee details»

Overview - GnuBIO

The power of the GnuBIO platform resides in the use of proprietary chemistry where the volume of reagents and/or analytes are extremely small. In the GnuBIO system, each droplet works as a โ€ฆSee details»

Bio-Rad Grows Droplet-Based DNA Sequencing Business with โ€ฆ

Apr 11, 2014 Bio-Rad Laboratories said today it acquired GnuBIO, in a deal that expands the acquiring companyโ€™s droplet-based DNA sequencing technology offerings within its portfolio of โ€ฆSee details»

Products - GnuBIO

The GnuBIO instrument encompasses all the steps required for DNA sequencing in a single platform including target selection and enrichment, DNA amplification, DNA sequencing and โ€ฆSee details»

News - GnuBIO

GnuBIO Unveils the Worldโ€™s First Prototype Fully Integrated DNA Sequencer at the Association of Molecular Pathology Conference Cambridge, Massachusetts โ€“ (October 24, 2012) โ€“ GnuBIO, โ€ฆSee details»

linkstock.net © 2022. All rights reserved